US SB4026 | 2021-2022 | 117th Congress
Status
Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on April 7 2022 - 25% progression, died in committee
Action: 2022-04-07 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 7 2022 - 25% progression, died in committee
Action: 2022-04-07 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend the Federal Food, Drug, and Cosmetic Act to grant eligible researchers access to eligible products at a discounted price for qualified research, and for other purposes.
Title
Discounted Drugs for Clinical Trials Act
Sponsors
| Sen. Tina Smith [D-MN] | Sen. Debbie Stabenow [D-MI] |
History
| Date | Chamber | Action |
|---|---|---|
| 2022-04-07 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB7472 (Related) 2022-04-08 - Referred to the Subcommittee on Health.
SB4053 (Related) 2022-04-07 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB4053 (Related) 2022-04-07 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/senate-bill/4026/all-info |
| Text | https://www.congress.gov/117/bills/s4026/BILLS-117s4026is.pdf |
